James Blachly (@jamesblachly) 's Twitter Profile
James Blachly

@jamesblachly

Hematologist and Computational Biologist. I am a doctor but I am not your doctor, this is not financial advice, and look both ways before crossing the street.

ID: 24837540

calendar_today17-03-2009 04:12:20

672 Tweet

708 Followers

438 Following

Lymphoma Hub (@lymphomahub) 's Twitter Profile Photo

CONGRESS | #ASH22 James Blachly, Ohio State presented early results from a study of MS-553, a highly selective PKC β inhibitor. Enrolled pts had #CLL or #SLL and were heavily pretreated. MTD was not reached. 48% of pts achieved PR/PRL with MS-553 monotherapy. #lymsm #hematology

CONGRESS | #ASH22
<a href="/jamesblachly/">James Blachly</a>, <a href="/OhioState/">Ohio State</a> presented early results from a study of MS-553, a highly selective PKC β inhibitor. Enrolled pts had #CLL or #SLL and were heavily pretreated. MTD was not reached. 48% of pts achieved PR/PRL with MS-553 monotherapy.
#lymsm #hematology
James Blachly (@jamesblachly) 's Twitter Profile Photo

Merry Christmas to all, even the person who paged me for not 1 but 2 routine hem consults at 11:45p on Christmas Eve and 1:30 am Christmas morning

J Mark Sloan (@jmarksloan) 's Twitter Profile Photo

You would think for a $730 registration and $375 membership fee ASH could just let us watch the education spotlight videos from #ASH22 at our leisure.

You would think for a $730 registration and $375 membership fee <a href="/ASH_hematology/">ASH</a> could just let us watch the education spotlight videos from #ASH22 at our leisure.
Chris Hourigan (@drchrishourigan) 's Twitter Profile Photo

Does anyone know the current policy of major oncology/hematology conferences regarding preprints? Especially for ASH. Submit before/with/after conference abstract? #leusm #BMTsm bioRxiv medRxiv

James Blachly (@jamesblachly) 's Twitter Profile Photo

GREAT WORK on folate role in hematopoietic development by briankrum1 presented as #ASH23 plenary scientific. 🙌🏻 I loved the first question which was a practical one: should we have BMT recipients supplement folate?

Chris Hourigan (@drchrishourigan) 's Twitter Profile Photo

Now, which clinical investigator is going to step up and dedicate themselves to doing the confirmatory prospective RCT? Biomarker available. A chance to change clinical practice.

James Blachly (@jamesblachly) 's Twitter Profile Photo

Menin inhibition will dramatically change the treatment of acute leukemia. We get first taste of this with KMT2A-r data on revumenib at #ASH23 LBA-5 ; can't wait for data on more drugs, new contexts, and combos 🚀 Great job Ibrahim Aldoss City of Hope !

Menin inhibition will dramatically change the treatment of acute leukemia. We get first taste of this with KMT2A-r data on revumenib at #ASH23 LBA-5 ; can't wait for data on more drugs, new contexts, and combos 🚀

Great job Ibrahim Aldoss <a href="/cityofhope/">City of Hope</a> !
James Blachly (@jamesblachly) 's Twitter Profile Photo

I'm two time zones west of home and >no way< am i making it to midnight here, so happy New Years to all and see you in 2024 🫂 It's snowing tho so I'll wake up early to make fresh tracks ⛷️

James Blachly (@jamesblachly) 's Twitter Profile Photo

In IHIS (the medical record) they removed the quick access icon indicating patient is on research and replaced it with a leaving-AMA button 🙄